Literature DB >> 1933613

Bone remodeling in osteoporosis associated with rheumatoid arthritis.

H Kröger1, I Arnala, E M Alhava.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1933613     DOI: 10.1007/bf02555104

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  7 in total

1.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

Review 2.  Tetracycline-based histological analysis of bone remodeling.

Authors:  H M Frost
Journal:  Calcif Tissue Res       Date:  1969

3.  The osteoporosis of rheumatoid arthritis.

Authors:  H Duncan; H M Frost; A R Villanueva; J W Sigler
Journal:  Arthritis Rheum       Date:  1965-10

4.  Determinants of axial bone loss in rheumatoid arthritis.

Authors:  P N Sambrook; J A Eisman; G D Champion; M G Yeates; N A Pocock; S Eberl
Journal:  Arthritis Rheum       Date:  1987-07

5.  Tetracycline double-labeling of iliac trabecular bone in 41 normal adults.

Authors:  F Melsen; L Mosekilde
Journal:  Calcif Tissue Res       Date:  1978-12-08

6.  Reduced bone formation in non-steroid treated patients with rheumatoid arthritis.

Authors:  J E Compston; S Vedi; R W Mellish; P Croucher; M M O'Sullivan
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

7.  Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.

Authors:  D M Reid; N S Kennedy; M A Smith; P Tothill; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31
  7 in total
  2 in total

Review 1.  Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.

Authors:  S R Goldring; E M Gravallese
Journal:  Arthritis Res       Date:  1999-12-22

Review 2.  Osteoblast Role in Rheumatic Diseases.

Authors:  Addolorata Corrado; Nicola Maruotti; Francesco Paolo Cantatore
Journal:  Int J Mol Sci       Date:  2017-06-15       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.